Fennec Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.

CEO

Rostislav C. Raykov

CEORostislav C. Raykov

Employees

Employees10

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

1996

Founded1996

Employees

Employees10

FENC Key Statistics

Market cap

263.39M

Market cap263.39M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

121.76K

Average volume121.76K

High today

—

High today—

Low today

—

Low today—

Open price

$9.40

Open price$9.40

Volume

0.00

Volume0.00

52 Week high

$10.85

52 Week high$10.85

52 Week low

$4.58

52 Week low$4.58

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

FENC Earnings

-$0.31

$0.04

$0.40

$0.75

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 28, Pre-Market

ActualExpected Feb 28, Pre-Market

Fennec Pharmaceuticals

Why Robinhood?

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. Show more

FENC Key Statistics

Analyst ratings

100%

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.